Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results
Benjamin L. Maughan, Adam Kessel, Taylor Ryan McFarland, Nicolas Sayegh, Roberto Nussenzveig, Andrew W. Hahn, John M. Hoffman, Kathyrn Morton, Deepika Sirohi, Manish Kohli, Umang Swami, Kenneth Boucher, Benjamin Haaland, Neeraj Agarwal
Dive into the research topics of 'Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results'. Together they form a unique fingerprint.